| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/STEM.2445 |
| P698 | PubMed publication ID | 27401837 |
| P50 | author | Stefano Ciciliot | Q42582579 |
| Gian Paolo Fadini | Q57544235 | ||
| Mattia Albiero | Q40107012 | ||
| P2860 | cites work | Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy | Q58816057 |
| Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes | Q24644691 | ||
| Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials | Q28082162 | ||
| Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell | Q28188430 | ||
| Haematopoietic stem cell release is regulated by circadian oscillations | Q28267721 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Endothelial progenitor cells: identity defined? | Q28303395 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Diabetes impairs hematopoietic stem cell mobilization by altering niche function | Q30543776 | ||
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data | Q30896351 | ||
| Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes | Q33222324 | ||
| Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy | Q33257976 | ||
| Diabetes mellitus induces bone marrow microangiopathy | Q33521433 | ||
| Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock | Q33590446 | ||
| Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling | Q33649290 | ||
| The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients | Q33662677 | ||
| Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment | Q33701168 | ||
| Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity | Q33724394 | ||
| Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. | Q41964589 | ||
| Stem cells on patrol | Q42069252 | ||
| Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair | Q42112447 | ||
| p38 mitogen-activated protein kinase downregulates endothelial progenitor cells | Q42475249 | ||
| Quality-control culture system restores diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure | Q42562746 | ||
| Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. | Q43168258 | ||
| Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: a meta-regression analysis. | Q43520400 | ||
| The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing | Q44203854 | ||
| Bone marrow-derived stem-cell repopulation contributes minimally to the Type II pneumocyte pool in transplanted human lungs | Q44578109 | ||
| Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice | Q44708287 | ||
| Vascular endothelial cadherin and beta-catenin in human fetoplacental vessels of pregnancies complicated by Type 1 diabetes: associations with angiogenesis and perturbed barrier function | Q45009706 | ||
| An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy | Q45267642 | ||
| Differential structural and functional changes in penile and coronary arteries from obese Zucker rats. | Q45960597 | ||
| Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. | Q46036417 | ||
| p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose | Q46100245 | ||
| Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans | Q46139385 | ||
| Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. | Q46464366 | ||
| Distinct bone marrow blood vessels differentially regulate haematopoiesis. | Q46564265 | ||
| Diabetes gets on the nerves of the bone marrow niche | Q47895621 | ||
| Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes | Q47907647 | ||
| Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy. | Q50505473 | ||
| Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. | Q51011615 | ||
| Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. | Q51073532 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis. | Q52929779 | ||
| Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells. | Q52993518 | ||
| Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy | Q39998481 | ||
| Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. | Q40037882 | ||
| NETosis Delays Diabetic Wound Healing in Mice and Humans. | Q40133978 | ||
| Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice | Q40730332 | ||
| Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients | Q40975241 | ||
| Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial). | Q41017688 | ||
| Diabetic hepatosclerosis: another diabetes microvascular complication? | Q41028828 | ||
| Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M. | Q41169174 | ||
| Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes. | Q41553791 | ||
| Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis | Q41940674 | ||
| Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes | Q33804692 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. | Q33871167 | ||
| The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. | Q33932817 | ||
| Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes | Q33960253 | ||
| Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. | Q33975637 | ||
| Rhythmic modulation of the hematopoietic niche through neutrophil clearance. | Q34026142 | ||
| Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease | Q34190328 | ||
| Diabetic autonomic neuropathy | Q34193010 | ||
| Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells | Q34250011 | ||
| Bone marrow failure and the telomeropathies | Q34431411 | ||
| Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization | Q34505828 | ||
| Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial | Q34511885 | ||
| Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals | Q34575418 | ||
| Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus | Q34653798 | ||
| A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans | Q34768452 | ||
| Bone marrow-derived TNF-α causes diabetic neuropathy in mice | Q34899309 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium | Q35185979 | ||
| Meta-analysis of cell therapy trials for patients with heart failure | Q35551127 | ||
| Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide | Q35563587 | ||
| Diabetes: impaired damage control | Q35587364 | ||
| CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. | Q35748620 | ||
| The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy | Q35764838 | ||
| Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor | Q35881779 | ||
| It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications | Q35882798 | ||
| Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications. | Q35998796 | ||
| Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. | Q36055443 | ||
| Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells | Q36132926 | ||
| Adrenergic nerves govern circadian leukocyte recruitment to tissues. | Q36191791 | ||
| Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? | Q36328639 | ||
| Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease. | Q36469490 | ||
| Stem-cell ecology and stem cells in motion | Q36528727 | ||
| Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues | Q36580764 | ||
| Immunological applications of stem cells in type 1 diabetes | Q36666422 | ||
| Diabetes impairs stem cell and proangiogenic cell mobilization in humans | Q36720330 | ||
| Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway | Q36739740 | ||
| Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway | Q36739754 | ||
| Stem cells and the regeneration of the aging cardiovascular system | Q36803362 | ||
| Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance | Q36808562 | ||
| Endothelial progenitor cell: a blood cell by many other names may serve similar functions | Q36991096 | ||
| Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia | Q37131598 | ||
| Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study | Q37163659 | ||
| Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model | Q37172543 | ||
| Assessing identity, phenotype, and fate of endothelial progenitor cells | Q37231424 | ||
| Arteriolar niches maintain haematopoietic stem cell quiescence. | Q37292035 | ||
| Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy. | Q37383408 | ||
| Autologous umbilical cord blood transfusion in very young children with type 1 diabetes | Q37400863 | ||
| Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes | Q37492370 | ||
| Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature | Q37594251 | ||
| Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis | Q37711215 | ||
| Potential manipulation of endothelial progenitor cells in diabetes and its complications | Q37768818 | ||
| Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair. | Q37805100 | ||
| Does microvascular disease predict macrovascular events in type 2 diabetes? | Q37901800 | ||
| Endothelial progenitor cells in diabetes mellitus. | Q38001402 | ||
| Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases | Q38048552 | ||
| Mechanisms of diabetic complications. | Q38072902 | ||
| Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond | Q38104104 | ||
| A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications. | Q38156645 | ||
| Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. | Q38310944 | ||
| MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus. | Q38311517 | ||
| Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence. | Q38562804 | ||
| Plasticity of hematopoietic stem cells | Q38641707 | ||
| Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies | Q38881908 | ||
| Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials | Q39464212 | ||
| Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival | Q39543700 | ||
| Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry. | Q39714506 | ||
| Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice | Q39963297 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 106-116 | |
| P577 | publication date | 2016-07-11 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes | |
| P478 | volume | 35 |
| Q64374717 | Bone marrow pericyte dysfunction in individuals with type 2 diabetes |
| Q92212788 | Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes |
| Q90069593 | Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche |
| Q64077617 | Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration-associated cells in diet-induced obese mice |
| Q90344621 | Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture |
| Q89537944 | Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence |
| Q39161927 | Immunotherapy for type 1 diabetes |
| Q89967666 | Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications |
| Q56979710 | Neuropathy and inflammation in diabetic bone marrow |
| Q51321906 | Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes. |
| Q97523350 | SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control |
| Q92730699 | Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence Are Damaged by In Vitro Exposure to its Dyslipidemic Serum, Predicting Inadequate Repair Capacity In Vivo |
| Q46539901 | Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes. |
Search more.